Deka Bank Deutsche Girozentrale Karyopharm Therapeutics Inc. Transaction History

Deka Bank Deutsche Girozentrale

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$5.21 - $8.61 $188,602 - $311,682	-36,200 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$14.14 - $19.71 $511,868 - $713,502	36,200 New	36,200 $515,000
Q4 2019 Feb 04, 2020	SELL	$9.23 - $19.67 $151,372 - $322,588	-16,400 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$5.66 - $11.85 $92,824 - $194,340	-16,400 Reduced 50.0%	16,400 $161,000
Q2 2019 Aug 01, 2019	BUY	$4.32 - $6.43 $56,160 - $83,590	13,000 Added 65.66%	32,800 $201,000
Q1 2019 May 10, 2019	BUY	$4.12 - $10.25 $14,008 - $34,850	3,400 Added 20.73%	19,800 $419,000
Q4 2018 Feb 12, 2019	SELL	$8.2 - $16.95 $27,879 - $57,630	-3,400 Reduced 17.17%	16,400 $152,000
Q3 2018 Nov 09, 2018	SELL	$17.03 - $21.18 $8,515 - $10,590	-500 Reduced 2.46%	19,800 $0
Q1 2018 May 03, 2018	BUY	$9.92 - $17.25 $201,376 - $350,175	20,300 New	20,300 $269,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $67.8M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.